Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intel Corp (INTC) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Intel CorpTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Intel Corp vs Vir Biotechnology Inc. Common Stock — how do they compare? Intel Corp trades at $95.47 (market cap $543.46B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Intel Corp is far larger — about 301.9× Vir Biotechnology Inc. Common Stock's market cap, and Intel Corp pays a 2.24% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intel Corp for 116 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

INTCVIR
Market Cap
$543.46B$1.80B
Volume
87,420,4051,782,836
Sector
TechnologyHealth
52-Week High
$140.94$11.78
52-Week Low
$33.62$5.12
Typical Hold Time
116 Days0 Days
Enterprise Value
$564.27B$1.36B
Dividend Yield
2.24%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intel Corp

Intel (INTC) trades at $102.81, up 1.44% with strong recent earnings beats but faces fundamental challenges including negative net income margin of -19.79% and elevated P/E ratio of 904.17. The stock has shown impressive 2026 momentum with three consecutive quarterly EPS beats, while technical indicators show mixed signals with bearish moving averages but bullish oscillators. Recent news highlights Intel's foundry turnaround efforts and 220% stock surge in 2026, though competition remains intense.

Intel presents a turnaround story with significant execution risks. The foundry business shows growth potential with 31% revenue increase, but negative profitability metrics and high valuation ratios suggest caution. Analyst consensus leans neutral with 54% hold ratings, while the $111.72 price target offers modest upside. Key risks include competitive pressures from TSMC and AMD, margin challenges, and the sustainability of recent stock gains.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INTC
54% Buy46% Sell
Avg holding period · 116 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Intel Corp

Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.

Read more on INTC →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →